News in the Life Sciences Industry

WATERBURY, Conn., Dec. 2, 2018 /PRNewswire/ -- Therap's reporting tools are used by Registered Nurses, LPNs, and other caregivers for minimizing medication errors. Therap's certified electronic health record software is used widely by nurses working at agencies that support individuals with intellectual... Read more ››

EAST HANOVER, N.J., Dec. 2, 2018 /PRNewswire/ -- Novartis announced results of a retrospective, real-world evidence study in patients with immune thrombocytopenia (ITP) treated with Promacta(® )(eltrombopag), compared to other second-line therapies. The data demonstrated that patients experienced... Read more ››

SAN DIEGO, Dec. 2, 2018 /PRNewswire/ -- Today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, presenters of three studies will highlight how recent technological developments are translating into clinically relevant advances for hard-to-treat blood... Read more ››

NORTH CHICAGO, Ill., Dec. 2, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the results of up to seven years of clinical trial follow-up for IMBRUVICA(®) (ibrutinib) monotherapy in chronic lymphocytic leukemia/small lymphocytic lymphoma... Read more ››

SAN DIEGO, Dec. 2, 2018 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that results from an ongoing Phase 1b study support the complementary potential of intermittent and continuous dosing schedules... Read more ››

CAMBRIDGE, Mass., Dec. 2, 2018 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced updated results for the Phase 1 EXPLORER clinical trial of avapritinib,... Read more ››

STOCKHOLM, Dec. 2, 2018 /PRNewswire/ -- Orphan Biovitrum AB (publ) (Sobi(TM)) and Bioverativ Inc., a Sanofi-company, today announced the final results of ASPIRE and B-YOND,... Read more ››

STOCKHOLM, Dec. 2, 2018 /PRNewswire/ --

NEW YORK, Dec. 1, 2018 /PRNewswire/ -- Petra Pharma Corporation, a drug development company focused on novel therapies that modulate phosphoinositide (PI) signaling pathways, today presented preclinical data in an oral presentation at the... Read more ››

NORTH CHICAGO, Ill., Dec. 1, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company today presented updated data from the pivotal Phase 3 MURANO trial of venetoclax (VENCLEXTA(®) or VENCLYXTO(®)) in combination with rituximab (VenR). The results at median... Read more ››

EAST HANOVER, N.J., Dec. 1, 2018 /PRNewswire/ -- New data from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab -- a once-a-month, humanized anti-P-selectin monoclonal antibody infusion being investigated for the treatment of sickle cell disease (SCD) -- shows greater reductions... Read more ››

SAN DIEGO, Dec. 1, 2018 /PRNewswire/ -- Today at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, researchers will announce findings from four studies that could greatly expand access to both curative and supportive treatments for individuals living with... Read more ››

CINCINNATI, Dec. 1, 2018 /PRNewswire/ -- A daily hydroxyurea pill may finally bring some relief for young children living with the painful and deadly blood disease sickle cell anemia (SCA) in resource-challenged sub-Saharan Africa, where the disease is prevalent and health care availability is... Read more ››